market perform
reason report
time buy turnaround continu sell-off elliott buy
bottom line upgrad md op margin
demand sell-off post elliott news friday view
buy opportun initi juli posit
bia particularli oper margin turnaround link
practic effici mm augment overhead reduct
mm post neonat demand remain secularli tepid
md specif strategi encouragingli lead volum growth
low- mid-singl digit outsiz share gain anesthesia
mix shift medicar remain headwind turnaround
drive bp margin expans
revenu mm mm ebitda
consensu turnaround neonat volum growth
revenu ebitda also consensu mm
mm respect line ebitda
guidanc appear achiev view remain
attract mm yield share repurchas
reauthor mm neonat roll-up
continu subject pipelin avail debt ebitda
also remain conserv view sell-off friday offer
buy opportun event driven money flush pt
contempl ev ebitda multipl
md turnaround opportun take hold pull
margin expans rais consensu
estim ebitda estim
mm mm mm respect
md improv margin expans outlook expect
mm improv potenti physician
practic effici md expect realiz mm
improv mm physician practic effici md
implement company-wid review individu physician group
creat individu oper plan includ initi drive revenu
growth provid satisfact oper improv exhibit
neonat demand remain flat though expect md could
see outsiz share gain return us birth rate millenni
would add increment growth md note past year
sever request propos rfp believ
opportun cross-sel product md oper subspecialti
pediatr matern line provid well-babi
care md hospit md would like doubl well cross-sel
compani inform leerink partner llc research
revenu mil dilut ep
net debt total capit
price-to-earnings lt ep growth
pleas refer page import disclosur price chart analyst certif
teleradiolog vrad organ growth driver creat cross-
sell opportun on-site practic md
break margin profil segment commentari suggest
radiolog margin anesthesia growth
segment aid organ margin stabil vrad provid cross-
sell opportun competit advantag rfp process
bring special radiolog servic often offer site exhibit
anesthesia mix continu headwind md activ
practic level review creat effici off-set comp
eas challeng began md face mix volum
headwind volum stabil mix pressur continu
comp eas partial off-set headwind
md yet seen tailwind elev price report
acut hospit could partial off-set mix pressur exhibit
md work opex initi hospit partner
improv staf md provid hospit partner
metric improv oper room util staf view
case anesthesiologist could replac one
guidanc appear achiev even minor hurrican
disrupt ebitda guidanc reflect southeast
anesthesia sac termin mm midpoint vs consensu
mm estim mm hurrican mm
impact view disrupt hurrican florenc
less last year impact exhibit
board announc new share repurchas program
expect md near term use repurchas share
 howev md expect close one neonat acquisit
ownership vrad creat strateg advantag
though valuat remain competit md pipelin tuck-in
larger acquisit exhibit
medium-term takeout potenti compani anticip evp
stephen farber assum addit role cfo novemb
mr farber previou experi knd cfo prior
op sale executive-in-resid warburg pincu
privat equiti activ healthcar servic sector
given md turnaround view compani could achiev multipl
near recent healthcar servic takeout averag ev/evitda
upgrad op rais pt pt
contempl ev/ebitda recent
pe takeout rang physician servic compani given improv
visibl margin expans opportun lack emerg
depart ed catalyst includ earn resolut aet
mp litig margin stabil exhibit
juli initi end tunnel
avail follow link
upgrad md op margin turnaround improv neonat share gain
despit flattish secular demand sell-off post elliott news friday view
buy opportun
initi juli posit bia particularli oper margin turnaround
link practic effici mm augment overhead reduct mm post
neonat demand remain secularli tepid md specif strategi encouragingli
lead volum growth low- mid-singl digit outsiz share gain anesthesia
mix shift medicar remain headwind turnaround drive bp margin
expans
revenu mm mm ebitda consensu
turnaround neonat volum growth revenu ebitda also
consensu mm mm respect line ebitda
guidanc appear achiev view
remain attract mm yield share repurchas
reauthor mm neonat roll-up continu subject pipelin
avail debt ebitda also remain conserv view sell-off
friday offer buy opportun event driven money flush pt
contempl ev ebitda multipl estim
md turnaround opportun take hold pull margin expans
rais consensu estim ebitda
estim mm mm mm respect md
improv margin expans outlook expect mm improv
potenti physician practic effici md expect realiz mm
improv mm physician practic effici md implement company-
wide review individu physician group creat individu oper plan includ
initi drive revenu growth provid satisfact oper improv
compani report leerink partner estim
maintain ebitda estim mm rais ebitda
estim mm mm respect reflect neonat share gain
continu acceler oper effici assum margin expand bp
bp
ebitda callin oper initi lack one-tim item sac definit expect posit margin posit growthw definit expect margin increas expect margin increas expect growth similar saw second quarter saw ebitda growth roughli say initi intend kind off-set headwind see macro environ given momentum seevivian lopez-blanco cfo treasur mednax mednax inc
compani report factset leerink research estim
consensusleerinkconsensusleerinkconsensusleerinkconsensusleerinkconsensusleerinkrevenu expense/net adjust ss top mm acquisit singl digit marginsphysician pract mm realiz mm target improv realiz wage increas premium pay staf additionssoutheast anesthesia revenu staf headwind contract endingpayor mix headwind anesthesia leerink ebitda inc
driver adjust ss top mm acquisit singl digit marginsphysician pract improv mm realiz improv mm realiz anesthesia revenu impact southeast anesthesiapayor mix headwind anesthesia leerink ebitda inc
neonat demand remain flat though expect md could see outsiz share gain
return us birth rate millenni would add increment growth md note
past year sever rfp believ opportun cross-sel
product md oper subspecialti pediatr matern line provid
well-babi care md hospit md would like doubl well cross-sel addit
birth declin recess recov
pre-recess level fertil rate remain near all-tim low growth
birth would increment posit increas millenni birthrat could drive segment
growth mm millenni give birth year millenni wait
later children comparison millenni women mom
compar gener similar age
teleradiolog vrad organ growth driver creat cross-sel opportun
on-site practic md break-out margin profil segment commentari
suggest radiolog margin anesthesia growth segment
aid organ margin stabil vrad provid cross-sel opportun competit
advantag rfp process bring special radiolog servic often offer site
teleradiolog also offer cross-sel opportun md radiolog outsourc
busi vrad overlap
anesthesia mix continu headwind md activ practic level review
creat effici off-set comp eas challeng began md face
mix volum headwind volum stabil mix pressur continu
comp eas partial off-set headwind md yet seen
tailwind elev price report acut hospit could partial off-set
medicar reimburs often less commerci insur reimburs
mix shift medicar present margin headwind accord medicar
reimburs often commerci versu medicaid
md work opex initi hospit partner improv staf md
provid hospit partner metric improv oper room util
staf view case anesthesiologist could replac one nurs
compani report leerink research estim
compani report leerink research estim
guidanc appear achiev view even minor hurrican disrupt
ebitda guidanc reflect southeast anesthesia termin mm midpoint
vs consensu mm estim mm hurrican mm impact
view disrupt hurrican florenc less last year impact
compani report factset leerink research estim
board announc new share repurchas program expect md
near term use repurchas share howev md expect close one
neonat acquisit ownership vrad creat strateg advantag
though valuat remain competit md pipelin tuck-in larger acquisit
compani report leerink research estim
compani report leerink research estim
medium-term takeout potenti new cfo stephen farber anticip compani
novemb previou experi knd cfo prior op sale
executive-in-resid warburg pincu privat equiti activ healthcar
servic sector given md turnaround view compani could achiev multipl
near recent healthcar servic takeout averag ev/evitda
compani report leerink research estim note athn propos takeout offer manag
accept
rais pt
upgrad op rais pt pt contempl
ev/ebitda recent pe takeout rang physician servic compani
given improv visibl margin expans opportun lack ed catalyst
includ earn resolut aet litig margin stabil
compani report factset leerink research estim
downsid risk valuat includ
continu shift ambulatori could impact patient volum
pressur birthrat could impact children servic volum
continu anesthesia mix shift medicar could impact margin
medicaid payment may face cut state sponsor face budget pressur
potenti cut medicar physician fee schedul
revenu could advers affect net loss contract
pt contempl ev/ebitda ebitda less nci estim
downsid risk valuat includ
substanti reduct govern reimburs
lower margin shift patient privat insur provid medicar
govern program advers consequ new on-going litig
out-of-network contract seek go in-network
futur unfavor polici chang dialysi
execut challeng adopt mircera calcimimet
incom statement mm except expensespractic salari benefit practic suppli oper gener administr total oper adjust depreci oper net interest pbt incom tax incom attribut md net incom attribut md averag share million dilut yoy dilut yoy growth growth supplies/net inc
